Tifanie Alberto

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.

Journal: Journal for immunotherapy of cancer

Published: May 28, 2026

Optic nerve and susceptibility imaging at asymptomatic stage of multiple sclerosis: impact and predictive value.

Optic nerve and susceptibility imaging at asymptomatic stage of multiple sclerosis: impact and predictive value.

Journal: Brain communications

Published: August 22, 2025

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: June 19, 2025

Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.

Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: October 15, 2024

Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results.

Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results.

Journal: Cancer immunology, immunotherapy : CII

Published: April 18, 2024

Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study.

Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study.

Journal: The Lancet regional health. Europe

Published: April 07, 2024

Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy.

Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: September 22, 2023

Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis.

Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis.

Journal: Brain communications

Published: June 27, 2023

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 07, 2022

Facial nerve palsy: an atypical clinical manifestation of COVID-19 infection in a family cluster.

Facial nerve palsy: an atypical clinical manifestation of COVID-19 infection in a family cluster.

Journal: European journal of neurology

Published: June 10, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026